Kaya F
Department of Ophthalmology, Istanbul Medipol University, Bagcilar, Istanbul, Turkey.
J Fr Ophtalmol. 2019 Apr;42(4):375-380. doi: 10.1016/j.jfo.2018.09.013. Epub 2019 Mar 21.
To evaluate the long-term results of corneal collagen cross-linking (CXL) with epithelium removal in patients with progressive keratoconus.
This retrospective study included 27 eyes of 18 patients who underwent CXL surgery for progressive keratoconus between April 2009 and March 2012. Best-corrected visual acuity (BCVA), manifest refraction spherical equivalent (SE), maximum keratometry reading (K max), mean of the minimum and maximum keratometry readings (mean-K), central corneal thickness (CCT), and anterior and posterior elevation at the apex preoperatively and year 1, 3 and 6 were evaluated and compared. P values<0.05 were considered to be statistically significant.
Mean BCVA was 0.35±0.28 logMAR preoperatively and 0.23±0.20 logMAR 6 years after the procedure (P=0.01). Mean SE decreased from -4.3±2.45 diopters (D) to -3.91±2.12 D (P=0.03). Mean K max decreased from 49.6±3.2 D to 48.6±2.8 D (P=0.04), and mean-K decreased from 47.6±2.5D to 46.9±2.6 D (P=0.04). CCT decreased insignificantly from 466.5±32.1μm to 465.4±26.6μm (P=0.65). Mean anterior elevation at the apex decreased from 12.8±7.9 to 12±8.3μm (P=0.04), and posterior elevation decreased from 27.1±17.4μm to 26.8±18.5μm (P=0.27). Mean-K, max-K, BCVA and CCT showed no change over the last 5 years. After the first year, no significant change was observed in BCVA, SE, max-K, mean-K and CCT, which were therefore considered stable. On the other hand, anterior and posterior elevation readings continued to decrease up to 6 years after CXL.
Based on our 6-year results, CXL can halt progression of keratoconus and reduce the need for keratoplasty.
评估去上皮角膜胶原交联术(CXL)治疗圆锥角膜患者的长期疗效。
这项回顾性研究纳入了2009年4月至2012年3月期间因圆锥角膜接受CXL手术的18例患者的27只眼。评估并比较术前、术后1年、3年和6年的最佳矫正视力(BCVA)、明显验光球镜等效度(SE)、最大角膜曲率读数(K max)、最小和最大角膜曲率读数的平均值(平均K)、中央角膜厚度(CCT)以及顶点处的前后高度。P值<0.05被认为具有统计学意义。
术前平均BCVA为0.35±0.28 logMAR,术后6年为0.23±0.20 logMAR(P = 0.01)。平均SE从-4.3±2.45屈光度(D)降至-3.91±2.12 D(P = 0.03)。平均K max从49.6±3.2 D降至48.6±2.8 D(P = 0.04),平均K从47.6±2.5D降至46.9±2.6 D(P = 0.04)。CCT从466.5±32.1μm降至465.4±26.6μm,下降不显著(P = 0.65)。顶点处的平均前表面高度从12.8±7.9降至12±8.3μm(P = 0.04),后表面高度从27.1±17.4μm降至26.8±18.5μm(P = 0.27)。平均K、最大K、BCVA和CCT在过去5年中无变化。术后第1年之后,BCVA、SE、最大K、平均K和CCT未观察到显著变化,因此被认为是稳定的。另一方面,CXL术后6年内,前后表面高度读数持续下降。
基于我们6年的研究结果,CXL可以阻止圆锥角膜的进展并减少角膜移植的需求。